483 Shanghai STA Pharmaceutical Product Oct 2021

483 Shanghai STA Pharmaceutical Product Oct 2021

Tonia Bernard FDA$119.00 - Available Now

FDA investigators audited the Shanghai STA Pharmaceutical Product - Shanghai, China facility and issued inspectional observations (via FDA 483) on 22 Oct 2021.

Product details

  • Category: Human Drugs
  • Inspection end: 22 Oct 2021
  • Location: Shanghai, China
  • FEI: 3014310427
Add To Cart